Evidence map›Paper›PMID 33335541›Full record

ArticleFrontiers in genetics2020

A Distributed Whole Genome Sequencing Benchmark Study.

Richard D Corbett, Robert Eveleigh, Joe Whitney, Namrata Barai, Mathieu Bourgey, Eric Chuah, Joanne Johnson, Richard A Moore, Neda Moradin, Karen L Mungall and 13 more

Abstract read
In one paragraph

Article in Frontiers in genetics, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

23 authors.

Richard D CorbettCanada's Michael Smith Genome Sciences Centre, BC Cancer Research Institute, Provincial Health Services Authority, Vancouver, BC, Canada.
Robert EveleighMcGill Genome Centre, McGill University, Montreal, QC, Canada.
Joe WhitneyThe Centre for Applied Genomics, The Hospital for Sick Children and University of Toronto, Toronto, ON, Canada.
Namrata BaraiThe Centre for Applied Genomics, The Hospital for Sick Children and University of Toronto, Toronto, ON, Canada.
Mathieu BourgeyMcGill Genome Centre, McGill University, Montreal, QC, Canada.
Eric ChuahCanada's Michael Smith Genome Sciences Centre, BC Cancer Research Institute, Provincial Health Services Authority, Vancouver, BC, Canada.
Joanne JohnsonCanada's Michael Smith Genome Sciences Centre, BC Cancer Research Institute, Provincial Health Services Authority, Vancouver, BC, Canada.
Richard A MooreCanada's Michael Smith Genome Sciences Centre, BC Cancer Research Institute, Provincial Health Services Authority, Vancouver, BC, Canada.
Neda MoradinThe Centre for Applied Genomics, The Hospital for Sick Children and University of Toronto, Toronto, ON, Canada.
Karen L MungallCanada's Michael Smith Genome Sciences Centre, BC Cancer Research Institute, Provincial Health Services Authority, Vancouver, BC, Canada.
Sergio PereiraThe Centre for Applied Genomics, The Hospital for Sick Children and University of Toronto, Toronto, ON, Canada.
Miriam S ReuterCanada's Genomics Enterprise (CGEn), The Hospital for Sick Children, Toronto, ON, Canada.
Bhooma ThiruvahindrapuramThe Centre for Applied Genomics, The Hospital for Sick Children and University of Toronto, Toronto, ON, Canada.
Richard F WintleThe Centre for Applied Genomics, The Hospital for Sick Children and University of Toronto, Toronto, ON, Canada.
Jiannis RagoussisMcGill Genome Centre, McGill University, Montreal, QC, Canada.
Lisa J StrugThe Centre for Applied Genomics, The Hospital for Sick Children and University of Toronto, Toronto, ON, Canada.
Jo-Anne HerbrickThe Centre for Applied Genomics, The Hospital for Sick Children and University of Toronto, Toronto, ON, Canada.
Naveed AzizCanada's Genomics Enterprise (CGEn), The Hospital for Sick Children, Toronto, ON, Canada.
Steven J M JonesCanada's Michael Smith Genome Sciences Centre, BC Cancer Research Institute, Provincial Health Services Authority, Vancouver, BC, Canada.
Mark LathropMcGill Genome Centre, McGill University, Montreal, QC, Canada.
Stephen W SchererThe Centre for Applied Genomics, The Hospital for Sick Children and University of Toronto, Toronto, ON, Canada.
Alfredo StaffaMcGill Genome Centre, McGill University, Montreal, QC, Canada.
Andrew J MungallCanada's Michael Smith Genome Sciences Centre, BC Cancer Research Institute, Provincial Health Services Authority, Vancouver, BC, Canada.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Population sequencing often requires collaboration across a distributed network of sequencing centers for the timely processing of thousands of samples. In such massive efforts, it is important that participating scientists can be confident that the accuracy of the sequence data produced is not affected by which center generates the data. A study was conducted across three established sequencing centers, located in Montreal, Toronto, and Vancouver, constituting Canada's Genomics Enterprise (www.cgen.ca). Whole genome sequencing was performed at each center, on three genomic DNA replicates from three well-characterized cell lines. Secondary analysis pipelines employed by each site were applied to sequence data from each of the sites, resulting in three datasets for each of four variables (cell line, replicate, sequencing center, and analysis pipeline), for a total of 81 datasets. These datasets were each assessed according to multiple quality metrics including concordance with benchmark variant truth sets to assess consistent quality across all three conditions for each variable. Three-way concordance analysis of variants across conditions for each variable was performed. Our results showed that the variant concordance between datasets differing only by sequencing center was similar to the concordance for datasets differing only by replicate, using the same analysis pipeline. We also showed that the statistically significant differences between datasets result from the analysis pipeline used, which can be unified and updated as new approaches become available. We conclude that genome sequencing projects can rely on the quality and reproducibility of aggregate data generated across a network of distributed sites.

Indexed as

benchmarkcomparisongenomeinformaticsvariantwhole genome sequencing

Identifiers

PMID33335541
PMCPMC7736078

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.